Hot Products

Regaloside D
Catalog No: CFN91842

Regaloside B analogue. Reference standards.

Regaloside F
Catalog No: CFN91798

Regaloside B analogue. Reference standards.

Regaloside H
Catalog No: CFN91799

Regaloside H, a phenylpropanoid glycerol glucoside, is a gluconeogenesis inhibitor. Regaloside H can reduce glucose production in Hepatocytes

Regaloside I
Catalog No: CFN95525

Regaloside I, which has the structure of phenylpropanolglycerol glycoside, acts as an active compound that inhibits the upregulation of CAPZA1 and inhibits UVA-induced changes in HDF shape, which in turn inhibits collagen reduction.

Regiolone
Catalog No: CFN96886

Regiolone demonstrates phytotoxicity. Regiolone also has anti-proliferative and apoptotic activities, it can induce apoptosis in MCF-7 cells through the caspase-3 independent pathway.

Regorafenib (BAY 73-4506)
Catalog No: CFN60043

Regorafenib (BAY 73-4506, Fluoro-Sorafenib) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM in cell-free assays, respectively. Regorafenib induces autophagy.

Rehmannic acid
Catalog No: CFN97738

Rehmannic acid and oleanolic acetate inhibit succinoxidase activity. Both Rehmannic acid and Icterogenin are potent uncouplers, abolishing the phosphate uptake, the respiration being inhibited by the former and increased by the latter.

Rehmannioside A
Catalog No: CFN90761

Rehmannioside A is an iridoid glucoside.

Rehmannioside C
Catalog No: CFN80135

Reference standards.

Rehmapicrogenin
Catalog No: CFN91691

Rehmapicrogenin, isolated from the root of Rehmannia glutinosa, exhibits potent anti-inflammatory effect by inhibiting iNOS, COX-2 and IL-6. Rehmapicrogenin attenuates kidney damage by reducing inflammatory factor release through the oestrogen signalling pathway.